Letters, Testimony & Comments
BIO commends the government of Colombia for taking steps towards developing regulatory requirements for the registry of medicines of...
February 22 2013
Biotechnology companies provide unique benefits to the United States and the world. In the health care sector alone, the industry has...
February 8 2013
BIO commends the INPI for their efforts to devise guidelines for examining biotechnology related inventions. Given the technological...
February 1 2013
BIO respectfully submits both questions and comments for the National Health Surveillance Agency’s (ANVISA) consideration on the...
February 1 2013
Given the importance of protections for basic biotechnology inventions to the survival of the biotechnology sector in India, BIO has...
January 18 2013
Draft Guidelines
Given the importance of protections for basic biotechnology inventions to the survival of the biotechnology...
November 28 2012
The Biotechnology Industry Organization (BIO) is grateful for the opportunity to provide comments on India’s Draft National IPR...
November 8 2012
Dear Commissioner Hamburg:
We are writing on behalf of the following higher education associations in consideration of issues raised...
November 5 2012
BIO supports the President’s decision to include Mexico in the TPP trade negotiations. Providing effective intellectual property...
September 4 2012
I. Agricultural and Animal Biotechnology
The Government of Canada has long been a trusted ally to the United States on agricultural...
September 3 2012
The Biotechnology Industry Organization (BIO) appreciates the U.S. Trade Representative's (USTR) query about BIO's views on how...
August 16 2012
The United States Patent and Trademark Office (USPTO) has led the world in providing technical expertise and training to various patent...
July 25 2012
Dear Chairman Smith and Ranking Member Conyers:
On behalf of the Biotechnology Industry Organization (BIO), I am writing to...
July 11 2012
The U.S. Intellectual Property Rights Attaché Program has had significant success and holds immense promise in helping to...
June 27 2012
On behalf of the 23 undersigned industrial, environmental, food and agricultural biotechnology companies, we write to express our...
June 11 2012
The House Judiciary Committee conducted a hearing on World IP Day on "International Patent Issues: Promoting...
April 25 2012
From BIO’s perspective, Supplemental Examination may have significant benefits, because patents that undergo this process are...
March 25 2012
Selected Excerpts:
The vast majority of BIO’s members are small and medium sized enterprises that currently do not have products...
March 7 2012
If a poor patient in Nevada doesn’t have access to an advanced molecular diagnostic test, and right across the border in California...
February 17 2012
BIO has identified the following countries of interest and recommends the following for our 2011 Special 301 submission.
Priority...
February 14 2012
January 30, 2012
Azam Khan
Deputy Chief of Staff,
Office of the Under Secretary and Director
United States Patent and...
January 30 2012
December 9, 2011
By Electronic Submission
To the State Intellectual Property Office,
The Biotechnology Industry Organization (BIO) appreciates this...
December 9 2011
By Electronic Submission
Ip.policy@uspto.gov
Office of Policy and External Affairs
United States Patent and Trademark Office...
November 10 2011
October 27, 2011
By electronic submission
Saurabh Vishnubhakat
Attorney Advisor,
Office of Chief Economist
United States Patent and Trademark...
October 27 2011
By electronic submission
Mr. Stan McCoy
Assistant USTR for Intellectual Property and Innovation
Office of the U.S. Trade...
October 20 2011
October 19, 2011
The Honorable David Kappos
Under Secretary of Commerce for Intellectual Property,
Director of the U.S. Patent & Trademark Office...
October 19 2011
June 14, 2011
Dear Chairman Smith:
On behalf of the Biotechnology Industry Organization (BIO), I am writing to express our strong support for your...
June 14 2011
June 13, 2011
Dear Speaker Boehner and Leader Pelosi:
We write to express our unified support for Section 22 of H.R. 1249, “The America Invents...
June 13 2011
May 13, 2011
Dear Secretary Locke:
On behalf of the Biotechnology Industry Organization (BIO) and the Pharmaceutical Research and Manufacturers of...
May 13 2011
April 1, 2011
Re: Request for Comments on the Strategy for American Innovation
Subject: Innovation Strategy RFI
Email: competitiveness@doc.gov
Dear...
April 1 2011
March 24, 2011
March 24, 2011
As our economy begins to improve, job creation remains a critical priority toward ensuring a broad, deep and sustained...
March 24 2011
February 25, 2011
Patent Amendment (Human Genes and Biological Materials) Bill 2010
Submission to the Senate Legal and Constitutional Affairs Legislation...
February 25 2011
February 15, 2011
The Biotechnology Industry Organization (BIO) appreciates the opportunity to participate in the Special 301 process and is hopeful that...
February 15 2011
January 13, 2011
Re: Microsoft Corp. v. i4i L.P. and Infrastructures for Information Inc., pending in the United States Supreme Court, No. 10-290...
January 13 2011
December 7, 2010
Re: IPR and Technology discussions at Cancún Climate Change Talks
Dear Secretary Clinton and Ambassador Stern:
At this very...
December 7 2010
November 22, 2010
RE: Participation of Malaysia in the Trans-Pacific Partnership Trade Negotiations
Dear Ms. Blue:
The Biotechnology Industry...
November 22 2010
November 19, 2010
Re: Request for Comments on Incentivizing Humanitarian Technologies and Licensing Through the Intellectual Property System, 75 Fed. Reg....
November 19 2010
October 14, 2010
October 14, 2010
To: Members of the Ad Hoc Open-ended Working Group on Access and Benefit-sharing of the Convention on Biological...
October 14 2010
October 14, 2010
District Court Ruling Exposes Biotechnology to Unprecedented Tort Liability. BIO disputes the District Court Ruling that exposes...
October 14 2010
September 29, 2010
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments on India’s Department of Industrial...
September 29 2010
July 26, 2010
Biotechnology companies would be less likely to export their products into countries that do not provide meaningful IP and data...
July 26 2010
June 1, 2010
BIO questions about the utility and expected impact of the proposal, and why patent applicants should be debited with subtractions from...
June 1 2010
May 27, 2010
Access to Early Capital
In the United States and globally, commercial development of biotechnology relies on the continuing...
May 27 2010
May 25, 2010
The Biotechnology industry Organization appreciates the opportunity to respond to the Request for Information issued by the Office of...
May 25 2010
February 18, 2010
Intellectual Property
Innovation and Chair of the Special 301 Committee
Office of the United States Trade Representative
Washington, D...
February 18 2010
February 4, 2010
February 4 2010
November 1, 2009
Dear Ms. Blue:
The Biotechnology Industry Organization (BIO) is submitting this letter in response to the request by the...
November 1 2009
October 8, 2009
Recommendations in the Secretary’s Advisory Committee on Genetics, Health and Society draft report on Gene Patenting and Licensing...
October 8 2009
October 8, 2009
October 8 2009
September 9, 2009
Dear Secretary Vilsack:
We are writing today to bring to your attention a court case that has the potential to negatively impact the...
September 9 2009
July 31, 2009
VIEWS AND PROPOSALS
OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) AND
THE PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF...
July 31 2009
July 15, 2009
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide the views of its members on intellectual property...
July 15 2009
June 1, 2009
U.S. Department of State
June 1 2009
May 15, 2009
May 15 2009
May 15, 2009
May 15 2009
April 30, 2009
Written Testimony of
The Biotechnology Industry Organization (BIO)
Before the United States House of Representatives...
April 30 2009
April 2, 2009
BIO commends the Senate Judiciary Committee for its success in developing a more consensus-oriented approach to patent reform legislation...
April 2 2009
March 19, 2009
March 19 2009
March 11, 2009
Office of the U.S. Trade Representative
March 11 2009
March 10, 2009
Written Testimony of
The Biotechnology Industry Organization (BIO)
Before the United States Senate
Committee on the...
March 10 2009
February 19, 2009
Office of the U.S. Trade Representative
February 19 2009
December 15, 2008
December 15 2008
November 24, 2008
COMMENTS OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) AND
THE PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PhRMA)
ON...
November 24 2008
October 13, 2008
BIO responds to a recent report entitled "Toward a New Era of Intellectual Property: From Confrontation to Negotiation" which offered no...
October 13 2008
July 3, 2008
The List of Options on Genetic Resources for Consideration by the Intergovernmental Committee on Genetic Resources, Traditional Knowledge...
July 3 2008
July 3, 2008
Comments of the Biotechnology Industry Organization (BIO) on the Draft Gap Analysis on the Protection of
Traditional Knowledge
July...
July 3 2008
May 2, 2008
Dear Chairman Pallone and Ranking Member Deal:
On behalf of the Biotechnology Industry Organization (BIO), I am writing to thank you...
May 2 2008
April 21, 2008
April 21 2008
February 28, 2008
Re: Sugestões ao projeto de lei que dispõe sobre o access tos recursos genéticos e seus derivados
Dear Sir/Madam...
February 28 2008
February 11, 2008
Re: Special 301: Identification of Countries Under Section 182 of the Trade Act of 1974: Request for Public Comment, 73 Fed. Reg. 2958 (...
February 11 2008
February 11, 2008
Office of the U.S. Trade Representative
February 11 2008
January 22, 2008
ACCESS AND BENEFIT-SHARING: PEER REVIEW PROCESS FOR ABS STUDIES
COMMENTS OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION
The...
January 22 2008
January 1, 2008
BIO commends the IGWG for its work on a global strategy and plan of action that, according to its mandate, will aim at "securing an...
January 1 2008
November 5, 2007
The Biotechnology Industry Organization
Presents a Luncheon Seminar:
From Biotechnology Innovation to Global Health Solutions:...
November 5 2007
October 30, 2007
The Comments of the
Biotechnology Industry Organization
on the United States Patent & Trademark Office
Proposed Rule Changes...
October 30 2007
October 24, 2007
The Biotechnology Industry Organization (BIO) appreciates this opportunity to provide the perspective of its members on the role of...
October 24 2007
October 17, 2007
COMMENTS OF THE BIOTECHNOLOGY INDUSTRY ORGANIZATION (BIO) ON ISSUES TO BE ADDRESSED BY THE TECHNICAL EXPERTS GROUP ON CONCEPTS, TERMS,...
October 17 2007
October 9, 2007
Attention: Kathleen Fonda
Comments to Notice of Proposed Rulemaking Entitled: Examination of Patent Applications That Include Claims...
October 9 2007
August 27, 2007
The Biotechnology Industry Organization (BIO) appreciates this opportunity tp provide the perspective of its members on the Bayh-Dole Act...
August 27 2007
August 16, 2007
The Biotechnology Industry Organization (BIO) appreciates the opportunity to provide comments on the U.S. Council for International...
August 16 2007
June 22, 2007
I'm writing on behalf of the Biotechnology Industry Organization (BIO) in response to your invitation for public comments on...
June 22 2007
June 6, 2007
Chairman Leahy, Ranking Member Specter, and Members of the Committee, I am pleased to testify before you today on the critically important...
June 6 2007
April 26, 2007
The Statement of the The Biotechnology Industry Organization On H.R. 1908, The Patent Reform Act of 2007
The United States House of...
April 26 2007
March 8, 2007
Office of the U.S. Trade Representative
March 8 2007
February 1, 2007
RE: Identification of Countries Under Section 182 of the Trade Act of 1974: Request for Public Comment, 72 Reg. 1033 (January 9, 2007)...
February 1 2007
October 23, 2006
To: Members of the TRIPS Council, World Trade Organization
From: The Presidents of the Biotechnology Industry Organization, BIOTECanada...
October 23 2006
October 6, 2006
Perhaps no other industry is as dependent upon patents as is the biotech industry. In 2004 alone, more than 10% of the PTO's...
October 6 2006
October 6, 2006
October 6 2006
September 18, 2006
Office of the U.S. Trade Representative
September 18 2006
September 9, 2006
Attention: Hiram H. Bernstein
Comments to Proposed Rulemaking Entitled: Changes to Information Disclosure Requirements and Other...
September 9 2006
August 28, 2006
To the State Intellectual Property Office of the People's Republic of China
August 28 2006
June 16, 2006
June 16 2006
June 9, 2006
Dear Ambassador Schwab:
The Russian Federation's accession to the World Trade Organization (WTO) would be an
important step forward...
June 9 2006
May 2, 2006
May 2 2006
March 24, 2006
Comments to the USTR touching on Intellectual Property Rights, Biosafety Protocol Implementation, Adventitious Presence, and Labeling.
March 24 2006
January 30, 2006
January 30 2006
November 20, 2004
Janna Tom, Assistant Director, Office of Technology Transfer, University of California; Vice President for Public Policy, Association of...
November 20 2004
November 5, 2004
Intervention of BIO
Agenda Item 7
Patent Disclosure Requirements relating to Genetic Resources
Thank you Mr. Chairman.
The...
November 5 2004
September 7, 2004
Dear Mr. Simon:
I write on behalf of the Biotechnology Industry Organization (BIO) in response to your request for views of European...
September 7 2004
April 16, 2004
April 16 2004
February 5, 2004
February 5 2004
February 5, 2004
February 5 2004
January 21, 2004
January 21 2004
December 10, 2003
December 10 2003
October 24, 2003
Dear House Leadership:
On behalf of the Biotechnology Industry Organization (BIO), I urge you to seek prompt passage of H.R. 1561, the...
October 24 2003
September 8, 2003
Earlier this year both the House and Senate passed their versions of a Medicare reform bill /1. Included in both the House and Senate...
September 8 2003
July 10, 2003
Chairman Bilirakis and Members of the Committee, I am pleased to testify before you today regarding technology transfer issues as they...
July 10 2003
April 3, 2003
April 3 2003
February 14, 2003
Identifying countries of concern as per the Trade Act of 1974
February 14 2003
January 29, 2003
Letter to The Honorable Robert Zoellick, US Trade Representative
January 29 2003
November 27, 2002
Letter to The Honorable Robert Zoellick, US Trade Representative
November 27 2002
October 24, 2002
The Honorable Mitchell E. Daniels, Jr.
Director, Office of Management and Budget
Dwight D. Eisenhower Executive Office Building, #252...
October 24 2002
October 2, 2002
Dear Senator Daschle:
The Biotechnology Industry Organization (BIO) strongly supports the Conference Agreement on the Department of Justice...
October 2 2002
September 20, 2002
Letter from BIO to the U.S. House of Representatives strongly urging members not to sign the discharge petition (H. Res. 517) offered by...
September 20 2002
July 15, 2002
Expressing strong concerns regarding S. 812 (McCain/Schumer- Edwards/Collins)
July 15 2002
June 14, 2002
The Honorable Thomas A. Daschle
509 Hart Senate Office Building
Washington, DC 20510
Dear Majority Leader Daschle:
...
June 14 2002
May 6, 2002
Under Secretary of Commerce for Intellectual Property and Director of the USPTO on Patent Harmonization
May 6 2002
May 6, 2002
May 6 2002
April 11, 2002
Summary
The biotechnology industry is the most research and development intensive and capital-focused industry in the world. The United...
April 11 2002
March 29, 2002
March 29 2002
March 21, 2002
Ranking Member of the House Judiciary Committee
March 21 2002
March 21, 2002
Chairman of the House Judiciary Subcommittee on Courts, The Internet, and Intellectual Property
March 21 2002
March 21, 2002
Ranking Member of the House Judiciary Subcommittee on Courts, The Internet, and Intellectual Property
March 21 2002
March 21, 2002
March 21 2002
February 26, 2002
The biotechnology industry is the most research and development intensive and capital-focused industry in the world. As such, it is very...
February 26 2002
November 15, 2001
Regarding funding for the U.S. Patent and Trademark Office
November 15 2001
October 1, 2001
Outling BIO opposition to generic biologic and pediatric rule codification amendments on pediatric exclusity bill.
October 1 2001
BIO letter to US House of Representatives Energy and Commerce Health Subcommittee Chairman Bilirakis
October 1, 2001
Outlining BIO opposition to generic biologic and pediatric rule codification amendments on pediatric exclusivity bill
October 1 2001
September 26, 2001
The Honorable Michael Harris, M.P.P.
Premier of Ontario
Legislative Assembly of Ontario
Room 281
Legislative Building
Toronto,...
September 26 2001
July 26, 2001
Honorable Michael Bilirakis
Chairman
Subcommittee on Health
Committee on Energy and Commerce
U.S. House of Representatives
2125...
July 26 2001
May 10, 2001
Executive Summary
The Biotechnology Industry Organization (BIO) supports amendment of the current reexamination authority to enhance patent...
May 10 2001
May 4, 2001
Acting Undersecretary of Commerce and Acting Director of the United States Patent and Trademark Office Regarding Patent Law Harmonization
May 4 2001
July 13, 2000
WASHINGTON, D.C. (July 13, 2000) -- Executives from two Biotechnology Industry Organization (BIO) member companies testified today...
July 13 2000
July 1, 1999
Executive Summary
The Biotechnology Industry Organization (BIO) supports reforms of the Hatch Waxman Act that will provide full day-for-...
July 1 1999
March 25, 1999
Executive Summary
BIO supports amendments to the patent law that, above all, ensure that diligent patent applicants are not penalized...
March 25 1999
RE: Notice of Public Hearing Concerning China's Compliance with WTO Commitments Written Comments (Federal Register Vol. 71, No. 145...
Every Year...
-of the 57 million people who die, 10.5 million are children under 5 years and 1.5 million are children between the ages...
Government's role in developing solutions for diseases that disproportionately affect developing countries
Introduction:
-...
National Institutes of Health: An International Perspective
NIH Mission:
To uncover new knowledge that will lead to improved public...
Innovation And The Global Research Enterprise
WORLD HEALTH ORGANIZATION
GENEVA—NOVEMBER 2007
THEODORE J. ROUMEL
VICE PRESIDENT...
Dear Senators Reid and McConnell:
On behalf of the more than 430 undersigned organizations representing American innovation
from all 50...
Dear Representative Issa:
I write on behalf of the Biotechnology Industry Organization (BIO) to commend your sponsorship of, and...
Key Documents
Letters, Testimony & Comments
February 22 2013
BIO commends the government of Colombia for taking steps towards developing regulatory requirements for the registry of medicines of...
February 8 2013
Biotechnology companies provide unique benefits to the United States and the world. In the health care sector alone, the industry has...
February 1 2013
BIO commends the INPI for their efforts to devise guidelines for examining biotechnology related inventions. Given the technological...
February 1 2013
BIO respectfully submits both questions and comments for the National Health Surveillance Agency’s (ANVISA) consideration on the...
January 18 2013
Given the importance of protections for basic biotechnology inventions to the survival of the biotechnology sector in India, BIO has...
Press Releases
February 11 2013
WHAT:
An inside look at two cases facing the Supreme Court of the United States: Bowman v....
January 15 2013
Washington, D.C. — The Biotechnology Industry Organization (BIO) and the American Seed Trade Association (ASTA...
June 21 2012
Washington, D.C. (June 21, 2012) – The Biotechnology Industry Organization (BIO) released a report on the...
June 20 2012
Intellectual property drives global economic development
WASHINGTON, DC – (June 20, 2012) – The...
April 18 2012
WASHINGTON, DC – (April 18, 2012) – Recent court decisions and ongoing implementation of the America...
Receive our newsletter from BIOtechNOW
Business Solutions Sponsor
